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English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom preparations 
suppressed TNF-α production, exhibiting IC50 values below 0.5 mg/ml in RAW 264.7 macrophages. 
Conclusion: In summary, anti-inflammatory activity in these food samples survived ‘cooking’. Provided 
that individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these 
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ABSTRACT  
 
Purpose  Chronic inflammatory processes contribute to the pathogenesis of many age-related diseases. In search 
of anti-inflammatory foods, we have systematically screened a variety of common dietary plants and 
mushrooms for their anti-inflammatory activity.  
Methods A selection of 115 samples was prepared by a generic food-compatible processing method involving 
heating. These products were tested for their anti-inflammatory activity in murine N11 microglia and RAW 
264.7 macrophages, using nitric oxide (NO) and tumour necrosis factor –  α (TNF-α) as pro-inflammatory 
readouts.  
Results Ten food samples including lime zest, English breakfast tea, honey brown mushroom, button mushroom, 
oyster mushroom, cinnamon and cloves inhibited NO production  in N-11 microglia with IC50 values below 0.5 
mg/ml. The most active samples were onion, oregano and red sweet potato, exhibiting IC50 values below 0.1 
mg/ml.  When these ten food preparations were re-tested in RAW 264.7 macrophages, they are all inhibited NO 
production similar to the results obtained in N-11 microglia. In addition, English breakfast tea leaves, oyster 
mushroom, onion, cinnamon and button mushroom preparations suppressed TNF-α production, exhibiting with 
IC50 values below 0.5 mg/ml in RAW 264.7 macrophages.  
Conclusion In summary, anti-inflammatory activity in these food samples survived ‘cooking’. Provided that 
individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these foods may 
be useful in limiting inflammation in a variety of age-related inflammatory diseases. Furthermore, these foods 
could be a source for the discovery of novel anti-inflammatory drugs.  
 
 
Keywords:  food, inflammation, cinnamon, oregano, oyster mushroom   
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1.  INTRODUCTION 
The increase in both the absolute number as well as relative proportion of the elderly is arguably one of the most 
important developments facing human society in the next decades [1]. Age is the leading risk factor for many 
devastating diseases such as acute and chronic neurodegenerative diseases, degenerative musculoskeletal 
diseases, cardiovascular diseases, diabetes, asthma, rheumatoid arthritis and inflammatory bowel disease. 
Increasing evidence suggests that systemic low grade inflammation is a contributing factor in these age-related 
diseases [2-6]. To date, pharmacotherapy of inflammatory conditions is based on the use of non-steroidal anti-
inflammatory drugs (NSAIDs). However, NSAIDs can cause serious gastrointestinal toxicity such as gastric 
bleeding and the formation of stomach ulcers [7, 8].  Even more ominously, some NSAIDs, particularly COX-2 
inhibitors, have been linked to increased blood pressure, greatly increased risk of congestive heart failure, 
occurrence of thrombosis and myocardial infarction [9-11].  Together, these findings provide the motivation for 
the development of anti-inflammatory treatments with fewer adverse effects.  
Herbal medicines derived from plants rich in the secondary metabolite salicylic acid such as the bark of the 
willow tree (Salix alba) have been used for the treatment of diseases with a prominent inflammatory component 
for thousands of years. Many other medicinal plants are known to have anti-inflammatory activity but neither 
the underlying mechanisms nor their potential for the development of new drugs have been fully explored. 
Several mechanisms are proposed to explain their anti-inflammatory action, including inhibition of 
cyclooxygenases and lipoxygenases or modulation of pro-inflammatory gene expression such as inducible nitric 
oxide synthase, and several pivotal cytokines including TNF-α [12, 13]. 
However, very few studies have attempted a systematic comparison of a large number of commercially 
available plant and mushroom foods in search of those with the highest degree of anti-inflammatory activities. 
To close this knowledge gap, we have screened 115 dietary plants and mushrooms for in vitro anti-inflammatory 
activities using a generic food-compatible sample processing method involving heating in water, or in the 
presence of glucose.  
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2.  MATERIALS AND METHODS 
2.1. Materials 
Plant and mushroom samples in the screening library were obtained from retail suppliers in Melbourne, 
Australia. DMSO, 95% ethanol, bovine serum albumin, lipopolysaccharide (LPS) (E.coli serotype 0127:B8), 
EDTA, N-(1-1-napthyl) ethylenediaminedihydrochloride, penicillin G sodium benzyl, resazurin sodium, 
streptomycin, sulfanilamide, tetra methyl benzidine (TMB), trypan blue were purchased from Sigma-Aldrich, 
(Castle Hill, NWS, Australia). Antibiotics, Dulbecco’s modified Eagle’s medium (DMEM), foetal bovine serum 
(FBS) and glutamine were purchased from Invitrogen (Mulgrave, Vic, Australia).  Murine IFN-γ and TNF-α 
ELISA kits were purchased from Peprotech (Rocky Hill, NJ, USA).  
 
2.2 Methods 
2.2.1 Preparation of the food and plant library samples  
Plant and mushroom library samples were prepared by methods usually employed with food preparation, 
involving heating (i.e. ‘cooking’), mechanical dispersion and treatments intended to solubilise both hydrophobic 
and hydrophilic solutes.  Samples were prepared by blending in a food processor with water (1:2 ratio w/v) 
before heating in a microwave for 10 min. under control conditions or including 1% glucose, to enhance 
Maillard reaction products. After cooling to room temperature, ascorbic acid (0.1% of initial solids) and ethanol 
(1% of initial solids) were added for microbial stabilisation. Samples were ultrasonicated using a 400 W probe 
at 100% power for 2 min. (Hielscher 400UPS) before freeze drying.     
 
2.2.2 Maintenance of N11 microglia and RAW 264.7 macrophages  
Cells were cultured in 175 cm2 flasks in DMEM containing 5% FBS, supplemented with glutamine (2 mM), 
penicillin (200 U/ml), streptomycin (200 μg/ml) and fungizone (2.6 μg/ml). The cell lines were maintained in 
5% CO2 at 37°C.  
 
  
5  
 
2.2.3 Pro-inflammatory activation of cells  
Cells were seeded at a density of 75,000 /well into each well of a 96-well plate. After 24h, a combination of 25 
μg/ml LPS and 10 U/ml IFN-γ diluted in DMEM was used for activation. The food samples were dissolved in 
DMEM and insoluble solids were removed by centrifugation at 16,900 x g for 2 min. Samples were added to the 
cells an hour prior to addition of the inflammatory activation mix at a maximal concentration of 2.5 mg/ml, from 
which 6 doses were made by serial 1:2  dilutions. Cells were incubated for 24 h at 37oC with the inflammatory 
activation mix before NO and TNF-α levels were measured.  
 
2.2.4 Measurement of nitrite levels by the Griess assay  
NO release was measured through the quantification of nitrite by the Griess assay. The Griess reagent was made 
up of equal volumes of 1% sulfanilamide and 0.1% napthyethylene-diamine in 5% HCl. From each well, 80 µl 
of cell culture medium was transferred to a fresh 96-well plate and mixed with 80 µl of Griess reagent and after 
30 minutes at room temperature absorbance was measured at 540 nm in a POLARstar Omega microplate reader 
(BMG Labtech, Mornington, Australia) and expressed as a percentage of that in control cells.  
 
2.2.5 Measurement of TNF-α levels by enzyme linked immunosorbent assay (ELISA)  
Determination of TNF-α was performed by ELISA, according to the manufacturer’s instructions (Peprotech) 
with minor modifications. Briefly, the capture antibody was diluted to 0.5 μg/ml in phosphate buffered saline 
(PBS; 1.9 mM NaH2PO4, 8.1mM Na2HPO4, 154 mM NaCl pH 7.4) and 100 μl of diluted capture antibody was 
added to each well of a 96-well plate, sealed with parafilm and incubated overnight at room temperature. The 
plate was washed 4 times with washing buffer (0.05% Tween-20 in PBS); 250 μl of blocking buffer (1% BSA in 
PBS) was added to each well, the plate was covered and incubated for 1 hour at room temperature. The plate 
was again washed 4 times in washing buffer. TNF-α standard was serially diluted from 0 to 10,000 pg/ml in 
diluent (0.05% Tween-20, 0.1% BSA in PBS). 50μl of cell supernatant or TNF-α standard in duplicate was 
added to each well, the plate was covered and incubated for 2.5 hours at room temperature. Each well was 
washed 4 times with washing buffer. Detection antibody was diluted to 0.125 μg/ml in diluent (supplied by the 
manufacturer) and 100 μl of diluted detection antibody was added to each well. The plate was covered and 
incubated for 2.5 hours before being washed 4 times with washing buffer. Avidin Peroxidase conjugate was 
diluted to a ratio of 1:4000 in diluent and 100μl of diluted Avidin Peroxidase conjugate solution was added to 
each well, the plate was covered and incubated for 30 minutes before being washed 4 times with washing buffer. 
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100μl of 3,3',5,5'-tetramethybenzidine (TMB) Liquid Substrate Solution (0.5 mg TMB dissolved in 1 ml 
DMSO, supplemented with 9ml phosphate-citrate buffer and 1µl 30% H2O2) was added to each well. 
Absorbance was measured at 655 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, 
Australia), taking readings every 5 min. After 25 min, the reaction was stopped using 0.5M sulphuric acid, and 
then the absorbance was measured at a wavelength of 455nm.  
 
2.2.6 Determination of cell viability  
The Alamar Blue assay is a colorimetric assay involving the cellular reduction of resazurin to resorufin. 
Resazurin was dissolved in PBS to give a concentration of 0.001% (w/v), sterile filtered (0.22 μm), protected 
from light with aluminium foil and stored at 4°C for up to six months. To determine cell viability, incubation 
media was aspirated from wells and replaced with 100 μl of resazurin solution and incubated at 37°C for 1 h.  
After incubation for 1 h, fluorescence of formed resorufin was measured with excitation at 530 nm and emission 
at 590 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, Australia) and expressed as a 
percentage of that in control cells, after background fluorescence was subtracted.  
 
2.2.7 Data calculation and statistics 
Data calculations were performed using MS-Excel 2010 software.  IC50 values were obtained by using the 
sigmoidal dose-response function in GraphPad Prism. IC50 values from three experiments were averaged (all 
performed in triplicate). The results were expressed as mean ± standard deviation. Differences between the same 
sample heated in water or glucose were analysed by t-tests using GraphPad Prism. 
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3.  RESULTS 
3.1 Primary screen of 115 food and mushroom samples using nitric oxide as pro-inflammatory readout  
115 commercially available dietary plants and mushrooms were selected (Table 1). Samples were prepared 
using a generic food-compatible sample processing method involving heating in water or in the presence of 1% 
glucose (to allow modification by the Maillard reaction for form Maillard reaction products, MRPs).   
These 115 samples (including 115 identical samples heated with glucose) were then tested for their ability to 
down-regulate LPS + IFN-γ induced NO production in N11 microglia (Table 1). Ten foods demonstrated 
significant anti-inflammatory activity with IC50 values below 0.5 mg/ml (Table 2).  Seven of these food 
preparations, including lime zest, English breakfast tea, honey brown mushroom, button mushroom, oyster 
mushroom, cinnamon and cloves demonstrated potent anti-inflammatory activity with IC50 values between 0.1 
and 0.5 mg/ml (Table 2).  However, the most active food samples were onion, followed by oregano and red 
sweet potato exhibiting IC50 values below 0.1 mg/ml (Table 3). Furthermore, the MRP modified samples 
showed IC50 values in the same order of magnitude as the unmodified samples and, despite significant 
differences in some samples between the unmodified and MRP modified samples, no general increase in anti-
inflammatory activity by the inclusion of glucose in the heating mixture could be detected. All of the active 
preparations were non-toxic at the IC50 values (cell viability > 75 %), suggesting that the reduction in NO 
production was not simply caused by a decrease in cell number or cell viability.  
Table 1:  List of food  and mushroom samples tested for their anti-inflammatory activity  
Category  Foods Botanical name Plant part used  Plant family or class of 
organism 
HERBS Continental parsley Petroselinium crispum dried aerial parts Apiaceae/Umbelliferae 
 Tarragon Artemisia dracunculus dried leaf Asteraceae/Compositae 
 Oregano Origanum vulgare dried leaf Lamiaceae/Labiatae 
 Rosemary Rosmarinus officinalis dried leaf Lamiaceae/Labiatae 
 Sage Salvia officinalis dried leaf Lamiaceae/Labiatae 
 Thyme Thymus vulgaris Dried leaf Lamiaceae/Labiatae 
SPICES Fennel Foeniculum vulgare seeds Apiaceae/Umbelliferae 
CONDIMENTS Coriander Coriandrum sativum seeds Apiaceae/Umbelliferae 
 Yellow mustard  Brassica hirta seeds Cruciferae 
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 Bay leaves Laurus nobilis leaves Lauraceae 
 Cinnamon Cinnamomum zeylanicum bark Lauraceae 
 Garlic Allium sativum bulb Lilliaceae 
 Brown linseed Linum Usitatissimum seeds Linaceae 
 Cloves Syzygium aromaticum flower buds Myrtaceae 
 Cardamom Elattaria cardamomum fruit Zingiberaceae 
 Ginger Zingiber officinale rhizome Zingiberaceae 
 Turmeric Curcuma longa rhizome Zingiberaceae 
VEGETABLES Spinach Spinacia oleracea aerial parts Amaranthaceae 
 Silver beet Beta vulgaris tuber Amaranthaceae 
 Rainbow silver beet Beta vulgaris tuber Amaranthaceae 
 Beet root Beta vulgaris tuber Amaranthaceae 
 Carrot Daucus carota tuber Apiaceae/Umbelliferae 
 Coriander  Coriandrum sativum leaves Apiaceae/Umbelliferae 
 Black carrot Daucus carota tuber Apiaceae/Umbelliferae 
 Asparagus Asparagus officinalis  Asparagaceae 
 Radiccio Cichorium intybus  Asteraceae/Compositae 
 Red coral lettuce Lactuca sativa aerial parts Asteraceae/Compositae 
 Bok Choi Brassica chinensis 
var.parachinensis 
fresh herb Cruciferae 
 Brussel srouts Brassica oleracea gemmifera? fresh herb Cruciferae 
 Chinese Broccoli Brassical oleracea fresh herb Cruciferae 
 Chinese cabbage Brassica rapa fresh herb Cruciferae 
 Choi sum Brassica chinenssis fresh herb Cruciferae 
 Red cabbage Brassica oleracea var.capitata 
rubra 
aerial parts Cruciferae 
 Savoy cabbage Brassica oleracea var savoy  Cruciferae 
 Water cress Nasturtium officinale  Cruciferae 
 Red Sweet Potato Ipomoea batatus tuber Convolvulaceae 
 Choko flesh Sechium edule fruit flesh Cucurbitaceae 
 Pumpkin Cucurbita maxima fruit Cucurbitaceae 
 Squash Cucurbita moschata fruit Cucurbitaceae 
 Choko skin Sechium edule skin Cucurbitaceae 
 Basil green Ocimum basilicum fresh herb Lamiaceae/Labiatae 
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 Basil purple Ocimum basilicum  fresh herb Lamiaceae/Labiatae 
 Basil Thai Ocimum basilicum var. 
thrysiflora 
fresh herb Lamiaceae/Labiatae 
 Green peas Pisum sativum seeds Leguminosae 
 Green beans    
 Chives Allium schoenoprasum bulb Lilliaceae 
 Leek Allium porrum herb Lilliaceae 
 Onion Allium cepa buld Lilliaceae 
 Shallot Allium cepa var. aggregatum bulb Lilliaceae 
 Spring onion Allium fistulosum bulb Lilliaceae 
 Red onion Allium cepa bulb Lilliaceae 
 Corn Zea mays seeds Poaceae 
 Lemon grass Cimbopogon citratus aerial parts Poaceae 
 Rhubarb Rheum palmatum  Polygonaceae 
 White potato  Solanum tuberosum tuber Solanaceae 
MARINE 
ALGEA  
Spirulina  Arthrospira platensis Whole organism Cyanobacteria 
FRUITS Kiwi Gold Actinidia chinensis  Actinidiaceae 
 Kiwi green Actinidia chinensis  Actinidiaceae 
 Cucumber Cucumis sativus  Cucurbitaceae 
 Zucchini white Cucurbita peop  Cucurbitaceae 
 Blueberries Vaccinium corymbosum  Ericaceae 
 Avocado Persea americana  Lauraceae 
 Coconut Cocos nucifera  Palmae 
 Quince Pyrus cydonia  Rosaceae 
 Raspberries Rubus idaeus  Rosaceae 
 Strawberries Fragaria X ananassa  Rosaceae 
 Apples Red delicious Malus domestica  Rosaceae 
 Ruby grapefruit Citrus paradisi  Rutaceae 
 Lime Citrus aurantifolia  Rutaceae 
 Mandarine (imperial) Citrus reticulata  Rutaceae 
 Lemon flesh Citrus limon  Rutaceae 
 Lime zest Citrus aurantifolia  Rutaceae 
 Oranges Navel Citrus sinensis  Rutaceae 
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 Oranges Valencia Citrus sinensis  Rutaceae 
 Orange zest Citrus sinensis  Rutaceae 
 Lemon zest Citrus limon  Rutaceae 
 Citrus yellow flesh Citrus limon  Rutaceae 
 Citrus red skin "  " 
 Citrus red flesh  "  " 
 Citrus yellow skin "  " 
 Citrus green "  " 
 Tomato Lycoperisicon esculentum  Solanaceae 
 Grapes M48-42 Vitis vinifera  Vitaceae 
 Grapes Chambourcin "  " 
 Grapes Cabernet 
Sauvignon 
"  " 
 Grapes M12-41 "  " 
 Grapes Sanmuscat "  " 
 Grapes Concord "  " 
 Grapes CR101-13 "  " 
 Grapes CR101-10 "  " 
MUSHROOMS Maitake Grifola frondosa fruit body Polyporaceae 
 Jew's ear Auricularia auricula-judae fruit body Auriculariaceae 
 Oyster Pleurotus ostreatus fruit body Pleurotaceae 
 Honey brown Agaricus bisporus fruit body Agaricaceae 
 Button Agaricus bisporus fruit body Agaricaceae 
 Enoki Flammulina veluptipes  fruit body Physalacriaceae 
 Shiitake Lentinus edodes fruit body Tricholomataceae 
BEVERAGES Coffe beans dark 
columbia 
Coffea arabica  Rubiaceae 
 Coffee beans  mocha Coffea arabica  Rubiaceae 
 Cocoa beans Theobroma cocoa  Malvaceae 
 Tea leaves English 
breakfast 
Camellia sinensis  Theaceae 
 Sencha tea leaves 
Japanese 
Camellia sinensis  Theaceae 
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Table 2:  Food samples with anti-inflammatory activity (IC50: 0.1 – 0.5 mg/ml)  
Food Sample Heated in IC50 for inhibition of NO 
production (mg/ml) 
Cell viability at IC50 for NO 
(%) 
Oyster mushroom water 0.47 ± 0.28 96 ± 6 
Oyster mushroom glucose 0.27 ± 0.10 98 ± 8 
Lime zest water 0.36 ± 0.06 108 ± 4 
Lime zest glucose 0.13 ± 0.04 93 ± 10 
Honey brown mushroom water 0.16 ± 0.13 106 ± 12 
Honey brown mushroom glucose 0.11 ± 0.04 104 ± 14 
Button mushroom water 0.14 ± 0.01 105 ± 15 
Button mushroom glucose 0.35 ± 0.01 124 ±  2 
English Breakfast Tea leaves water 0.24 ± 0.13 94 ± 3 
English Breakfast tea leaves glucose 0.30 ± 0.21 92 ± 2 
Cinnamon water 0.21 ± 0.10 88 ± 12 
Cinnamon glucose 0.29 ± 0.14 89 ± 14 
Cloves water 0.28 ± 0.06 83 ± 5 
Cloves glucose 0.15 ± 0.01 95 ± 9 
 
Table 3: Food samples with anti-inflammatory activity (IC50< 0.1mg/ml)  
Food sample Heated in IC50 for inhibition of NO 
production (mg/ml) 
Cell viability at IC50 for NO 
(%) 
Onion water 0.087 ± 0.030 99 ± 5 
Onion glucose 0.075 ± 0.010 101 ± 1 
Oregano water 0.066 ± 0.020 96 ± 2 
Oregano glucose 0.083 ± 0.030 96 ± 3 
Red sweet potato water 0.067 ± 0.020 95 ± 7 
Red sweet potato glucose 0.054 ± 0.020 90 ± 5 
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Table 4: Food samples re-tested in RAW 264.7 macrophages 
Food Sample IC50 for NO production 
(mg/ml) 
IC50 for TNF-α 
production  (mg/ml) 
LC50  (mg/ml) 
Onion 0.13 ± 0.02 0.30 ± 0.01 > 2.5 
Oregano 0.13 ± 0.01 0.73 ± 0.06 > 2.5 
Oyster mushroom 0.07 ± 0.01 0.23 ± 0.02 > 2.5 
Red sweet potato 1.54 ± 0.10 0.51 ± 0.03 > 2.5 
Lime zest (glucose) 0.41 ± 0.05 1.02 ± 0.11 > 2.5 
Honey brown mushroom 0.81 ± 0.03 1.0 3± 0.14 > 2.5 
Button mushroom 0.73 ± 0.01 0.39 ± 0.04 > 2.5 
Cinnamon 0.10 ± 0.01 0.45 ± 0.01 > 2.5 
Cloves 0.12 ± 0.01 2.12 ± 0.02 > 2.5 
English breakfast tea leaves 0.40 ± 0.01 0.30 ± 0.02 > 2.5 
Anti-inflammatory drug     
Prednisone 
 
0.25 ± 0.09 
(0.69 ± 0.26 mM) 
0.7 ± 0.07 
(1.95 ± 0.21 mM) 
1.36 ± 0.21 
(3.81 ± 0.59 mM) 
Ibuprofen 
 
0.79 ± 0.08 
(3.83 ± 0.43 mM) 
0.42 ± 0.16 
(1.19 ± 0.16mM) 
0.34 ± 0.09 
(1.63 ± 0.44 mM) 
 
3.2 Secondary screen using a second cell line (RAW 264.7 macrophages) and nitric oxide plus TNF-α as 
pro-inflammatory readouts 
The 10 most active samples (defined as having an IC50 value of < 0.5 mg/ml or 0.1 mg/ml, respectively) with 
demonstrated anti-inflammatory properties from the primary screen were retested in a second cell line with an 
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additional pro-inflammatory readout, TNF-α. Since the previous experiment did not show any striking 
difference between the original and glucose-modified preparations, no glucose-modified samples were used in 
the second screen, except for lime zest, where the availability of the unmodified sample was limited.  
These 10 active samples (English breakfast tea leaves, onion, oregano, oyster mushroom, red sweet potato, lime 
zest,  honey brown mushroom, button mushroom, cinnamon and cloves) were tested by measuring their ability 
to down-regulate LPS + IFN-γ induced release of NO and, as a second marker of inflammation, TNF-α (Table 
4). 
Of the 10 products, oyster mushroom and cinnamon, demonstrated the most significant anti-inflammatory 
activities (with IC50 values below 0.1 mg/ml), followed by cloves, oregano, onion, English breakfast tea leaves 
and lime zest (with IC50 values below 0.5 mg/ml) in terms of suppression of LPS and IFN-γ induced NO 
production.  In addition, English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom 
preparations also suppressed TNF-α release (with IC50 values below 0.5 mg/ml). Oyster mushroom was the most 
active anti-inflammatory sample for both NO inhibition and TNF-α inhibition with IC50 values 0.067 mg/ml and 
0.23 mg/ml respectively (Table 4). 
In addition, two anti-inflammatory drugs, including prednisone and the non-steroidal anti-inflammatory drug 
(NSAID) ibuprofen were tested in the same assay systems. Ibuprofen was toxic to cells at concentrations of 1.63 
± 0.44 mM, and NO and TNF-α production were down-regulated at the same concentrations (Table 4). 
Prednisone inhibited LPS + IFN-γ induced NO and TNF-α production with IC50 values of 0.25 ± 0.09 mg/ml 
(0.69 ± 0.26 mM) and 0.7 ± 0.07 mg/ml (1.95 ± 0.21 mM), respectively (Table 4).  
 
4.  DISCUSSION 
The activation of macrophages and microglia leads to secretion of inflammatory molecules such as the pro-
inflammatory cytokine TNF-α and the free radical NO, which play an important role in inflammation and 
nitroxidative stress in many age-related diseases, including Alzheimer’s disease (AD) [14]. In the assay systems 
used here, the bacterial surface molecule lipopolysaccharide and the cytokine IFN-γ were used to activate 
microglia, and NO and TNF-α release were used as readouts [15].  
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As control substances, the synthetic corticosteroid prednisone and the non-steroidal anti-inflammatory drug 
(NSAID) ibuprofen were also tested in the same assay systems. As expected, ibuprofen as a selective COX-1 
and 2 inhibitor did not specifically inhibit LPS and IFN-γ induced NO and TNF-γ production. Interestingly, 
prednisone was quite a weak inhibitor of LPS + IFN-γ induced NO and TNF-α production, since in many other 
inflammatory paradigms corticosteroids are effective at low micromolar, and in some instances at nanomolar 
concentrations [13]. However, it appears that macrophages treated with a combination of LPS and IFN-γ 
(compared to LPS alone) are insensitive to anti-inflammatory corticosteroids such as dexamethasone [14, 15], 
which is consistent with our observations.  
Among the food samples, one hundred and fifteen distinct plants and mushroom preparations were screened for 
anti-inflammatory properties by employing in vitro cell-based bio-assays. The extracts of several plants 
including onion, oregano, red sweet potato, lime zest, cinnamon and cloves exhibited the strongest capacity to 
suppress NO and TNF-α. Interestingly, oyster mushroom, honey brown mushroom and button mushroom 
showed also significant anti-inflammatory potential.  
Interestingly, a differential effect of MRP modification on the activity of the food preparations was observed, 
depending on the sample. Since high molecular MRPs (also termed advanced glycation endproducts, AGEs) are 
known to increase inflammation [16, 17], and low molecular MRPs (MW < 1 kDa)  have been shown to possess 
anti-inflammatory potential [18], it might be the balance between these species which shift the IC50 value up or 
down depending on the composition of the sample.  
Some of our data are in accordance with published studies on anti-inflammatory properties of the foods 
identified as potent in this study. For example, onions have been shown to exhibit anti-inflammatory properties, 
e.g. downregulation of adipokine expression in the visceral adipose tissue of rats or attenuation of vascular 
inflammation and oxidative stress in fructose-fed rats [19, 20]. Among the polyphenols in onions, quercetin was 
suggested to be the responsible anti-inflammatory ingredient, as evidenced by the downregulation of COX2 
transcription in human lymphocytes [21]. Furthermore, the anti-inflammatory activity of the onion has been 
studied also in relation to the presence of thiosulfinates and cepaenes [22, 23].  
Anti-inflammatory properties of cinnamon has been demonstrated for Cinnamomum osmophloem kaneh [24, 
25], but less is known about the ‘true’ cinnamon of India, Cinnamomum zeylanicum. Some authors reported 
significant inhibitory effects of inflammatory signalling by the extracts of C. cassia [26]. Sodium benzoate 
appears to be one of the active ingredients in cinnamon, since it inhibits LPS-induced expression of inducible 
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NO synthase (iNOS), pro-inflammatory cytokines (TNF-α and IL-1β) and surface markers for inflammatory 
activation such as CD11b, CD11c, and CD68 in mouse microglia [27].  
Clove (Syzygium aromaticum) extracts have been identified as having potent free radical (including superoxide 
anion) scavenging properties, and metal chelating activities, which may be due to the presence of flavonoids. 
Cloves contain considerable concentrations of eugenol, beta-caryophyllene, quercetin and kaempferol as well as 
rhamnetin and kaempferol and their glycosides [28]. Our study is in line with studies showing that eugenol 
suppresses NF-κB activation, thereby down-regulating cyclooxygenase-2 expression in lipopolysaccharide-
stimulated macrophages [29-31].  
Red sweet potato (Ipomoea batatas), a species rich in β-carotene and anthocyanins [32], has been demonstrated 
to have anti-inflammatory properties for the first time by our study.  Lime (Citrus aurantifolia) rich in flavonol 
glycosides, especially of kaempferol-type are known for their anti-oxidant properties [33], however our  study is 
also the first to report on its anti-inflammatory activities.  
The anti-inflammatory properties of the various mushroom species were quite surprising, since there are only a 
handful studies showing such activity. For example, oyster mushroom concentrate (OMC) was shown to 
suppress LPS-induced secretion of TNF-α, IL-6 and IL-12p40 in RAW264.7 macrophages and also suppressed 
PGE2 and NO by down-regulation of COX-2 and iNOS expression, respectively. OMC also inhibited LPS-
dependent DNA binding activity of AP-1 and NF-κB in RAW264.7 cells [34]. Our results correlate with these 
observations as oyster mushroom extracts inhibited LPS+IFN-γ induced production of NO. In mushrooms, 
water-soluble polysaccharides, especially the β-glucans, are most likely to be the substances responsible for the 
anti-inflammatory properties. For example, β-glucans isolated Pleurotus ostreatus were able to potentiate the 
anti-inflammatory effects of methotrexate in rat models of experimental arthritis or colitis [35, 36]. A further 
potential anti-inflammatory compound in mushrooms could be ergothioneine (ET), a sulfur containing amino 
acid that functions as an antioxidant and is present in mushrooms at a concentration of up to 2.0mg/g [37]. In 
Acute Respiratory Distress Syndrome (ARDS), ergothioneine given intravenously 1h before or 18 h after 
cytokine (IL-1 and IFN-γ) insufflation, decreased lung injury and lung inflammation in cytokine insufflated rats 
[38]. 
In summary, it is suggested that foods containing anti-inflammatory properties might be useful in the prevention 
of age-related inflammatory conditions, provided that dose and individual bioavailability lead to therapeutic 
concentrations in affected tissues. Bioavailability of plant substances including polyphenols is highly variable, 
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and will depend on the nature of the compound [39, 40]. Therefore, validation of the active samples in animal 
models should eventually follow. Furthermore, we speculate that these natural sources could lead to the 
discovery of potent novel anti-inflammatory compounds.  
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